Synopsis:
- Dr. Reddy’s Laboratories Ltd. on Monday introduced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency scenario for COVID-19 in India.
- A press launch from the drug maker mentioned Dr. Reddy’s had submitted its software for approval to the DCGI in December 2021, along with knowledge from medical trial in Russia, following its Phase-III medical trial of the single-shot Sputnik Light vaccine in India.
Sputnik Light is a single-dose vaccine and the identical as the primary part — recombinant human adenovirus serotype quantity 26 (rAd26) — of the two-dose Sputnik V vaccine.
Sputnik Light has been permitted in over 30 nations all over the world together with Argentina, UAE, Philippines and Russia.
The standalone Sputnik Light vaccine is the newest jab to be permitted by the DCGI as a part of India’s nationwide inoculation effort in opposition to COVID-19. Sputnik Light is the second COVID-19 vaccine to be made out there in India by Dr. Reddy’s, reaffirming the corporate’s dedication to discover each avenue within the combat in opposition to the pandemic, it mentioned.
Sputnik Light has been permitted in over 30 nations all over the world together with Argentina, UAE, Philippines and Russia. In April 2021, the DCGI granted approval to the two-dose Sputnik V vaccine for restricted use in emergency scenario in India.
